SynsoryBio
YC W24Boston, US · Founded 2023 · 2 employees · 2 known investors
SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.
Founders & leadership· Y Combinator alumni (W24)
SynsoryBio was founded in 2023 by Elliot Tague and Nathan Tague.
ET
Elliot TagueinFounderElliot Tague holds a PhD and has worked in synthetic biology and protein engineering, including time as a visiting graduate student in George Church's lab at Harvard and roles at various biotech startups.
NT
Nathan TagueinFounderNathan Tague holds a PhD in Biomedical Engineering and has expertise in synthetic biology and protein engineering. He is a co-founder of SynsoryBio, a therapeutics company developing sense-and-respond treatments.
Investors · 2
In the news
Frequently asked questions
- What does SynsoryBio do?
- SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.
- Who founded SynsoryBio?
- SynsoryBio was founded by Elliot Tague, Nathan Tague in 2023.
- Who are SynsoryBio's investors?
- SynsoryBio's investors include Y Combinator, Axial VC.
- Where is SynsoryBio headquartered?
- SynsoryBio is headquartered in Boston, US.